Neal Olarte
Cardiovascular Disease · Sacramento, CANPI 1669835617
Payments from drug & device makers
Across 341 payments — averaging $277.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$49K
- Medtronic$22K
- Boston Scientific$10K
- Biotronik Inc.$7K
- Medical Device Business Services, Inc.$3K
- Shockwave Medical, Inc$1K
- plus $2K from 17 others
What the payments were for
- Grants$60,54364%
- Travel & lodging$19,75421%
- Food & beverage$13,25814%
- Education$9521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 89 | $48,598 |
| Medtronic | 100 | $22,313 |
| Boston Scientific | 35 | $10,198 |
| Biotronik Inc. | 20 | $6,940 |
| Medical Device Business Services, Inc. | 19 | $3,354 |
| Shockwave Medical, Inc | 21 | $1,236 |
| Biosense Webster, Inc. | 13 | $398 |
| Akcea Therapeutics, Inc. | 15 | $391 |
| Abiomed | 4 | $176 |
| Baxter Healthcare | 1 | $149 |
| Penumbra, Inc. | 1 | $143 |
| Cook Incorporated | 1 | $141 |
| Johnson & Johnson | 5 | $103 |
| Edwards Lifesciences | 4 | $85 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $70 |
| Impulse Dynamics (USA) Inc. | 1 | $46 |
| Novartis | 3 | $42 |
| Ancora Heart, Inc. | 1 | $28 |
| Sobi, Inc | 1 | $22 |
| Pfizer | 1 | $21 |
| Endotronix, Inc. | 1 | $20 |
| W. L. Gore & Associates, Inc. | 1 | $17 |
| Cardiva Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIENCE V$9,000
- ENSITE PRECISION$3,129
- Carto 3$2,999
- EnSite Precision Cardiac Mapping System$1,119
- ENSITE$1,087
- HeartMate Touch$958
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$946
- AVEIR$435
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$197
- RESOLUTE ONYX$154
- Hillrom - Cardiac Ambulatory Monitor$149
- Indigo System$143
- MitraClip$133
- ACCOLADE SR$119
- CardioMEMS HF System$112
- TEGSEDI$107
How this compares
$94,506 in reported general payments places this provider in the 90th percentile of 2,184 cardiovascular disease providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $19,134 |
| MultaqDronedarone Hcl | 14 | $17,551 |
| Mexiletine Hcl | 11 | $492 |
| Metoprolol Succinate | 14 | $215 |
| Amiodarone Hcl | 23 | $213 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $21 | $19,13423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,184 cardiovascular disease providers in California.
Other cardiovascular disease in Sacramento
- Jason RogersSacramento$5.1M
- Gagan SinghSacramento$2M
- Jeffrey SouthardSacramento$1.8M
- Thomas SmithSacramento$942K
- Ted LoveHillsborough$102.8M
- Matthew BudoffTorrance$11.3M
- Lori DanielsSan Diego$10.2M
- Paul KurthSanta Barbara$6.1M
- Michael BlumSan Francisco$5.5M
- Tony ChouSan Francisco$5.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.